Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
11 /100
LOW RISK
Score updated Oct 13, 2026

HRMY — Harmony Biosciences Holdings, Inc. Dilution Risk Tracker

Track HRMY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HRMY — Get alerts when the score changes →

As of October 13, 2026, Harmony Biosciences Holdings, Inc. (HRMY) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. Harmony Biosciences Holdings, Inc. has a market capitalization of $2.23B, 58.24M shares outstanding, 317 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for HRMY.
🔔 Track HRMY — Get forecast alerts →

Market Data

Market Cap$2.23B
Shares Outstanding58.24M
Float51.73M
Cash$667.79M
Debt$153.96M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore11/100DilutionWatch score record
Shares Outstanding58.24MVerified float table or market cache
Public Float51.73MVerified float table or market cache
Market Cap$2.23BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 4, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 20.8% shares (2026Q1 vs prior)
317 institutional holders · 61.95M shares
#1 BlackRock, Inc. 7.07M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.20M shares
#3 FMR LLC 3.16M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.53M
Days to Cover5.0
% of Float10.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-02-21
4 INSIDER TRANSACTION 2026-04-09
3 FORM3 2026-04-06
4 INSIDER TRANSACTION 2026-04-06
4 INSIDER TRANSACTION 2026-04-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual HRMY Dilution Snapshot

Harmony Biosciences Holdings, Inc. (HRMY) has a DilutionScore of 11/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

HRMY's DilutionScore is currently 11/100 (Low risk), with 3 score changes tracked over 89 days. The score improved from 10/100 (Low risk).

Period Score Risk Level Duration
Oct 13, 202611/100LOW1 day
Oct 10 – Oct 12, 202610/100LOW3 days
Aug 14 – Oct 09, 202623/100LOW56 days
Jul 16 – Aug 13, 202619/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

HRMY shares outstanding have increased 0.0% from 57.87M (Apr 2026) to 57.89M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 28, 202657.89M51.73M▲ 0.02%
May 08, 202657.87M51.72M▲ 0.09%
Apr 09, 202657.87M51.68M▲ 1.52%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track HRMY Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment HRMY files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking HRMY — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for HRMY
HRMY FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.